A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.


Updates from The Motley Fool

Latest updates on Celldex Therapeutics from Fool.com.  The Fool has written over 200 articles on Celldex Therapeutics.
How to Invest in Biotech Stocks

The biotech sector is full of millionaire-maker stocks. But how do you separate the gems from the...



Stock Performance

View Interactive CLDX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celldex Therapeutics.
Current Price: $0.51
Prev Close: $0.51
Open: $0.52
Bid: $0.51
Ask: $0.52
Day's Range: $0.51 - $0.52
52wk Range: $0.48 - $3.26
Volume: 825,136
Avg Vol 3,067,390
Market Cap: $70M
P/E (ttm): -0.40
EPS (ttm): ($1.28)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celldex Therapeutics.
CAPS Rating 4 out of 5
 
361 Outperform
16 Underperform
CAPS All Stars
 
66 Outperform
6 Underperform

How do you think Celldex Therapeutics will perform against the market?



You pick for Celldex Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Celldex Therapeutics.

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers